NCT01746836
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +14 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
Explore clinical trials studying Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia. Study availability and eligibility vary by location and protocol.
4 public trials
1 recruiting study
Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia trial results
NCT00254423
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +13 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02311998
- Conditions
- B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Crisis, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +21 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia
NCT02689440
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +13 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States